At the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential targets. (2022)

First Author: Jurj A
Attributed to:  Enhancing immunogenicity in non-viral low mutation burden tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.annonc.2022.10.507

PubMed Identifier: 36456103

Publication URI: http://europepmc.org/abstract/MED/36456103

Type: Journal Article/Review

Volume: 33

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 12

ISSN: 0923-7534